Innovex Q1 2026 Results Announced; Details Still Pending

What happened

Innovex International announced its first quarter 2026 results on May 4, 2026, but the initial release provided no financial figures or commentary. The DeepValue report from January 2026 rated the stock a WAIT at $25.47, citing that the price already discounts high margins and strong cash flow that are partly flattered by asset sales and non-cash items. Without concrete numbers, investors cannot assess whether adjusted EBITDA margins held above 18% or if free cash flow conversion remained robust. The key catalysts—subsea transformation and the OneSubsea ramp—remain unconfirmed, leaving the investment thesis in limbo. Until detailed results are released, the stock’s risk/reward is unchanged from the previous assessment.

Implication

The DeepValue report's WAIT stance persists as the stock at ~$25.47 leaves limited upside to the $28 base case and substantial downside to $18 in a bear scenario. Investors should hold off buying until details reveal whether adjusted EBITDA margins remain above 18% and free cash flow is structurally strong ex asset sales. A pullback toward $21 would offer a more attractive entry if margins hold.

Thesis delta

No material shift—the thesis remains unchanged as we await Q1 2026 details. The report's WAIT rating is maintained; any upgrade or downgrade depends on the actual numbers.